In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of BioXcel Therapeutics Inc (NASDAQ: BTAI) closed at $0.58 in the last session, down -12.13% from day before closing price of $0.66. In other words, the price has decreased by -$12.13 from its previous closing price. On the day, 1.01 million shares were traded. BTAI stock price reached its highest trading level at $0.67 during the session, while it also had its lowest trading level at $0.5766.
Ratios:
We take a closer look at BTAI’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 2.25 and its Current Ratio is at 2.35.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, UBS on February 21, 2024, Downgraded its rating to Neutral and sets its target price to $4 from $9 previously.
On August 15, 2023, Mizuho Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $40 to $4.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Sep 16 ’24 when Yocca Frank sold 355 shares for $0.69 per share. The transaction valued at 245 led to the insider holds 14,203 shares of the business.
Mehta Vimal sold 1,982 shares of BTAI for $1,367 on Sep 16 ’24. The CEO and President now owns 51,666 shares after completing the transaction at $0.69 per share. On Sep 16 ’24, another insider, Steinhart Richard I, who serves as the Chief Financial Officer of the company, sold 356 shares for $0.69 each. As a result, the insider received 246 and left with 6,204 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BTAI now has a Market Capitalization of 23492876 and an Enterprise Value of 70844856. For the stock, the TTM Price-to-Sale (P/S) ratio is 9.79. Its current Enterprise Value per Revenue stands at 29.482 whereas that against EBITDA is -0.679.
Stock Price History:
Over the past 52 weeks, BTAI has reached a high of $5.62, while it has fallen to a 52-week low of $0.53. The 50-Day Moving Average of the stock is -31.47%, while the 200-Day Moving Average is calculated to be -72.83%.
Shares Statistics:
According to the various share statistics, BTAI traded on average about 631.41K shares per day over the past 3-months and 854390 shares per day over the past 10 days. A total of 40.74M shares are outstanding, with a floating share count of 32.53M. Insiders hold about 20.17% of the company’s shares, while institutions hold 24.14% stake in the company. Shares short for BTAI as of 1724976000 were 680476 with a Short Ratio of 1.08, compared to 1722384000 on 807305. Therefore, it implies a Short% of Shares Outstanding of 680476 and a Short% of Float of 2.15.
